A SNAI2-PEAK1 stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting a cytokine expression profile that converges on PI3K/Akt signaling
S. Hamalian, R. Güth, F. Runa, J. Molnar, E. Vickers, M. Agajanian, J. D. Humphries, M. J. Humphries, J. C. Tchou, I. Zervantonakis, J. Kelber
bioRxiv · May 15, 2020Cancer Biology